FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
about
Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen.Chemotherapy for colorectal cancer in the elderly.Senior adult oncology.Palliative chemotherapy in advanced colorectal cancer patients 80 years of age and olderOxaliplatin-based chemotherapy in the management of colorectal cancer.Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patientsChallenges in the management of older patients with colon cancerReintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.Targeted agents: review of toxicity in the elderly metastatic colorectal cancer patients.Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1.Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable diseaseClinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy.Effectiveness and safety of intensive triplet chemotherapy plus bevacizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer patients.Patient's age should not play a key role in clinical decisions on surgical treatment of rectal cancer.Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer.Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.Advanced age and liability to oxaliplatin-induced peripheral neuropathy: post hoc analysis of a prospective study.
P2860
Q30244769-E035D507-962D-4D33-8DD9-E8A98935A81FQ33778129-7BDC6829-FA3F-414F-AE6C-6C8614EA5195Q35567604-D30B636B-CF6A-4CB3-A5ED-E59E14C1EE9FQ36851424-BB57EB61-9B24-49A3-854B-7C0A484C85D8Q36989058-6DD93043-6EF5-41EB-97C7-A4E138C8AE7AQ37242664-51DF285D-1DF6-4528-B6DF-915D8F606F23Q37318017-0CA857F1-8DD4-490F-B0C9-0D52768280EDQ37598467-10F59AF1-EECF-4CBE-B9FF-02EB89997512Q37859220-D4E8693F-E9BB-4DE8-8D2B-FD2E401B3CABQ37954162-C9855AC0-5C84-441A-8A12-36C0C6329404Q38228522-6D5ECD22-9E47-417B-A7F8-2D4640DC71E2Q38534405-2A2B881E-5B9E-4885-98B0-1E0B358F6B54Q39381763-76A7E40D-E6B7-49A1-BDA0-1DD662D3B82FQ40888760-91D6DF4E-A138-41C4-BCF0-D40FE1F9D670Q41044367-2BC16EDD-F506-49B4-9F5E-4D90C44990E0Q42870892-C4692468-9DED-45CF-8280-C149D9A7A5E9Q43704593-AB87E500-FAE1-48B6-874D-7455C6FDADEBQ44102658-46A4C6E6-E7E6-4184-B9A5-7D9C01F59D85Q50222120-378B72F1-21AD-41BC-9B54-72C1A19F773DQ50887433-58BBD58E-A0A1-446E-A9C9-AC747FA0A482
P2860
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
FOLFOX in patients aged betwee ...... cohort of the OPTIMOX1 study.
@en
FOLFOX in patients aged betwee ...... cohort of the OPTIMOX1 study.
@nl
type
label
FOLFOX in patients aged betwee ...... cohort of the OPTIMOX1 study.
@en
FOLFOX in patients aged betwee ...... cohort of the OPTIMOX1 study.
@nl
prefLabel
FOLFOX in patients aged betwee ...... cohort of the OPTIMOX1 study.
@en
FOLFOX in patients aged betwee ...... cohort of the OPTIMOX1 study.
@nl
P2093
P2860
P356
P1433
P1476
FOLFOX in patients aged betwee ...... cohort of the OPTIMOX1 study.
@en
P2093
Aimery de Gramont
Andre Cervantes
Arié Figer
Christophe Louvet
Christophe Tournigand
Elisabeth Carola
Gerard Lledo
Michel Flesch
Nathalie Perez-Staub
Philippe Colin
P2860
P304
P356
10.1002/CNCR.23091
P407
P577
2007-12-01T00:00:00Z